Shares of Ceapro Inc. (CVE:CZO – Get Free Report) dropped 11.8% on Tuesday . The stock traded as low as C$0.23 and last traded at C$0.23. Approximately 5,849 shares traded hands during mid-day trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Stock Performance
The firm has a market cap of C$17.62 million, a PE ratio of -3.75 and a beta of 1.38. The company has a 50-day simple moving average of C$0.22 and a two-hundred day simple moving average of C$0.23. The company has a quick ratio of 18.88, a current ratio of 8.54 and a debt-to-equity ratio of 8.07.
Ceapro Company Profile
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Read More
- Five stocks we like better than Ceapro
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- What is the Nasdaq? Complete Overview with History
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
